Literature DB >> 1658032

Impaired intrathyroidal iodine organification and iodine-induced hypothyroidism in euthyroid women with a previous episode of postpartum thyroiditis.

E Roti1, R Minelli, E Gardini, L Bianconi, T Neri, G Gavaruzzi, G Ugolotti, D Salvo, L E Braverman.   

Abstract

Postpartum thyroiditis (PPT) is common and occurs in 1.7 to 16.7% of pregnant women, depending upon the study population. Most of these women develop transient hypothyroidism and thyroid function usually returns to normal. We have studied 11 euthyroid women with a previous history of PPT to determine the incidence of subtle defects in thyroid function measured by iodide-perchlorate (I-ClO4) discharge tests and TRH tests and to determine whether these women would develop iodide-induced hypothyroidism. Seven (64%) had positive I-ClO4 discharge tests and 5 (46%) had an abnormally high TSH response to TRH. Thyroid antimicrosomal and antithyroid peroxidase were positive in 8 women (73%) with a previous episode of PPT. The administration of pharmacological amounts of iodide (10 drops of saturated solution of potassium iodide daily) for 90 days to these 11 women resulted in elevated basal and TRH stimulated serum TSH concentrations in 8 (72.7%) compared to TSH values during iodide administration to women who had never been pregnant. Antimicrosomal and antithyroid peroxidase concentrations did not change during iodide administration. These findings strongly suggest that euthyroid women with a previous episode of PPT have permanent subtle defects in thyroid hormone synthesis and are inordinately prone to develop iodide-induced hypothyroidism, similar to findings previously reported in euthyroid subjects with Hashimoto's thyroiditis, with a previous episode of painful subacute thyroiditis, or previously treated with radioactive iodine or surgery for Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658032     DOI: 10.1210/jcem-73-5-958

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Post-partum thyroiditis in South Brazil presenting as thyrotoxicosis: prevalence and risk factors.

Authors:  T W Furlanetto; M O Premaor; M L Caramori; B C Frantz; G Z Patta; E Tatto; A G Vaz
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.

Authors:  S Mariotti; A Loviselli; S Murenu; F Sau; L Valentino; A Mandas; S Vacquer; E Martino; A Balestrieri; M E Lai
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

3.  Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis.

Authors:  F Bogazzi; E Dell'Unto; M L Tanda; L Tomisti; C Cosci; F Aghini-Lombardi; C Sardella; A Pinchera; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

4.  2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.

Authors:  Tomasz Bednarczuk; Thomas H Brix; Wolfgang Schima; Georg Zettinig; George J Kahaly
Journal:  Eur Thyroid J       Date:  2021-06-16

5.  Age as a predictor of recurrent hypothyroidism in patients with post-partum thyroid dysfunction.

Authors:  F Azizi
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

6.  Selenium administration does not cause thyroid insufficiency in subjects with mild iodine deficiency and sufficient selenium intake.

Authors:  E Roti; R Minelli; E Gardini; L Bianconi; A Ronchi; A Gatti; C Minoia
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

7.  Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy.

Authors:  F Bogazzi; L Bartalena; L Tomisti; E Dell'Unto; C Cosci; C Sardella; M L Tanda; A Lai; M Gasperi; F Aghini-Lombardi; E Martino
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

8.  Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.

Authors:  R Minelli; E Gardini; L Bianconi; M Salvi; E Roti
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

9.  Prevalence of anti-thyroid peroxidase antibodies in autoimmune and nonautoimmune thyroid disorders in a relatively low-iodine environment.

Authors:  M Knobel; M F Barca; F Pedrinola; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.